2017 Medicare Part-D Plans in Puerto Rico

2017 Medicare Part-D Plans in Puerto Rico

There are 6 Medicare Part-D Plans available in Puerto Rico from 4 different health insurance providers. You can choose from 1 prescription drug plans offering additional gap coverage. The plan with the lowest monthly premium is $12 and the highest monthly premium is $74. The highest rated PDP available in Puerto Rico County received a 4 overall star rating from the CMS and the lowest rated plan is 3 stars.

(Click the Plan Name for More Details)

Plan Name Monthly
Type Gap
$0 Premium
Full LIS
Plan Rating Formulary
AARP MedicareRx Preferred (PDP)
$55.30 $400.00 Basic No NoSee The
EnvisionRxPlus (PDP)
$62.70 $400.00 Basic No NoSee The
Express Scripts Medicare - Choice (PDP)
$74.50 $350.00 Enhanced No NoSee The
Express Scripts Medicare - Value (PDP)
$53.10 $400.00 Basic No NoSee The
Humana Enhanced (PDP)
$47.30 $0.00 Enhanced Yes NoSee The
Humana Preferred Rx Plan (PDP)
$12.90 $400.00 Basic No NoSee The
Return 2017 Medicare Part D Plans
2017 Medicare Advantage in Puerto Rico

Benefit Type

Enhanced Alternative plans may offer additional gap coverage which is calculated as the percentage of generic formulary products with coverage above standard "generic" coverage gap cost-sharing benefit and/or the percentage of brand formulary products covered in addition to the coverage gap discount for applicable drugs.


In 2017 once you and your plan provider have spent $3700 on covered drugs. (combined amount plus your deductible) You will be in the coverage gap. (AKA "donut hole") Once you reach the coverage gap you will pay 40% of the plans cost for covered brand-name prescription drugs and 51% on generic drugs unless your plan offers additional coverage. You will still receive a 60% discount on brand-name drugs and a 49% discount on generic drugs.

Source: CMS.gov

Plans as of September 6, 2016.

Plans are subject to change as contracts are finalized.

Includes 2017 approved contracts/plans. Employer sponsored 800 series plans and plans under sanction are excluded. For 2017, enhanced alternative plans may offer additional cost sharing reductions in the gap on a sub-set of the formulary drugs, beyond the standard Part D benefit.